do-me/EUR-LEX huggingface dataset:
Case C-716/24, Ponner: Request for a preliminary ruling from the Oberlandesgericht Frankfurt am Main (Germany) lodged on 22 October 2024 – EJ
Date: 2024-10-22
Institutions: Court of Justice
Subjects: bank deposit, branch, debt, financial solvency, judicial cooperation in civil matters in the EU, payment, seizure of goods, subsidiary, third country








C_202500883EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/883


17.2.2025






Request for a preliminary ruling from the Oberlandesgericht Frankfurt am Main (Germany) lodged on 22 October 2024 – EJ


(Case C-716/24, Ponner)
                (1)

(C/2025/883)
Language of the case: German

Referring court

Oberlandesgericht Frankfurt am Main

Parties to the main proceedings


Applicant and appellant: EJ

Questions referred







1.


Must Article 2(c) of Regulation (EU) No 655/2014, (2) read in conjunction with Recital 8 of Regulation No 655/2014, be interpreted as meaning that the opening of insolvency proceedings not covered by Regulation (EU) 2015/848, (3) but conducted in a third country, precludes the issuing of an account preservation order under Article 7(1) of Regulation No 655/2014 or the forwarding of the request for account information under Article 14(3) of Regulation No 655/2014 if the national law of the Member State responsible for issuing the account preservation order recognises the insolvency proceedings in the third country concerned?










2.


Must the first sub-paragraph of Article 14(1) and (3) of Regulation No 655/2014 – namely the ‘reasons to believe that the debtor holds one or more accounts with a bank in a specific Member State’ to be provided by the creditor and ‘well substantiated’ – be interpreted as meaning that circumstances which do not specifically indicate the existence of an account in the Member State concerned, but which generally imply strong economic links between the debtor and the Member State concerned, such as, for example, payments to the debtor via a payment service provider with registered office in the Member State concerned which is a subsidiary of the debtor, or the existence of an agency or branch of the debtor with registered office in that Member State?






(1)  The name of the present case is a fictitious name. It does not correspond to the real name of any party to the proceedings.

(2)  Regulation of the European Parliament and of the Council of 15 May 2014 establishing a European Account Preservation Order procedure to facilitate cross-border debt recovery in civil and commercial matters (OJ 2014 L 189, p. 59).

(3)  Regulation of the European Parliament and of the Council of 20 May 2015 on insolvency proceedings (recast) (OJ 2015 L 141, p. 19).


ELI: http://data.europa.eu/eli/C/2025/883/oj
ISSN 1977-091X (electronic edition)
Information communicated by member states regarding closure of fisheries
Date: 2024-10-22
Institutions: Directorate-General for Maritime Affairs and Fisheries, European Commission
Subjects: EU waters, Mediterranean Sea, Spain, catch by species, catch quota, fishing area, fishing rights, sea fish, sea fishing








C_202406372EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/6372


22.10.2024






Information communicated by member states regarding closure of fisheries
(C/2024/6372)

In accordance with Article 35(3) of Council Regulation (EC) No 1224/2009 of 20 November 2009 establishing a Union control system for ensuring compliance with the rules of the common fisheries policy (1), a decision has been taken to close the fishery as set down in the following table:






Date and time of closure


28.6.2024




Duration


28.6.2024 – 31.12.2024




Member State


Spain




Stock or Group of stocks


ALB/MED (including ALB/MED-BC and ALB/MED-SR)




Species


Mediterranean Albacore (Thunnus alalunga)




Zone


Mediterranean Sea




Type(s) of fishing vessels


—




Reference number


15/TQ257






(1)  
            OJ L 343, 22.12.2009, p. 1.


ELI: http://data.europa.eu/eli/C/2024/6372/oj
ISSN 1977-091X (electronic edition)
Case C-721/24, Vista-Life Pharma and Vista-Life Pharma Belgium: Request for a preliminary ruling from the Cour d’appel de Bruxelles (Belgium) lodged on 22 October 2024 – Vista-Life Pharma SA, Vista-Life Pharma Belgium SCRL v Laboratoires S.M.B. SA, Brussels Reps Pharma SRL
Date: 2024-10-22
Institutions: Court of Justice
Subjects: Internet site, advertising, consumer information, foodstuff, illness, labelling, packaging, product designation








C_202500708EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/708


10.2.2025






Request for a preliminary ruling from the Cour d’appel de Bruxelles (Belgium) lodged on 22 October 2024 – Vista-Life Pharma SA, Vista-Life Pharma Belgium SCRL v Laboratoires S.M.B. SA, Brussels Reps Pharma SRL


(Case C-721/24, Vista-Life Pharma and Vista-Life Pharma Belgium)

(C/2025/708)
Language of the case: French

Referring court

Cour d’appel de Bruxelles

Parties to the main proceedings


Appellants: Vista-Life Pharma SA, Vista-Life Pharma Belgium SCRL

Respondents: Laboratoires S.M.B. SA, Brussels Reps Pharma SRL

Questions referred







1.


Is Article 2(2)(1) and (5) of Regulation No 1924/2006 (1) to be interpreted as meaning that the expressions ‘particular characteristics’ and ‘a food category, a food or one of its constituents’ cover statements relating to the frequency of intake and/or the route of administration of the foodstuff?










2.


Is Article 14(2) of Regulation No 1924/2006 to be interpreted as requiring the labelling or, if no such labelling exists, the presentation or advertising to reproduce verbatim the statement indicating that the disease to which the claim is referring ‘has multiple risk factors and … altering one of these risk factors may or may not have a beneficial effect’?










3.


Is Article 14(2) of Regulation No 1924/2006 to be interpreted as requiring that advertising which contains the reduction of disease risk claim must include the statement indicating that ‘the disease to which the claim is referring has multiple risk factors and that altering one of these risk factors may or may not have a beneficial effect’ where that statement appears on the packaging, leaflet and/or website of the product?






(1)  Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods (OJ 2006 L 404, p. 9).


ELI: http://data.europa.eu/eli/C/2025/708/oj
ISSN 1977-091X (electronic edition)